• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Philips Launches Advanced 3D Imaging Navigation Platform for Faster Lung Cancer Diagnosis

by Fred Pennic 09/21/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
advanced 3D imaging and navigation platform

What You Should Know:

– Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform with the launch of Azurion Lung Edition.

– By speeding diagnosis and treatment, Azurion Lung Edition is helping to transform lung cancer care, contributing to dramatically improved outcomes and reduced costs.


Royal Philips, today announced the launch of Azurion Lung Edition, an advanced 3D imaging and navigation platform to accelerate the diagnosis and treatment of lung cancer. The suite combines CT-like 3D images acquired at the tableside (Cone Beam CT) with live X-ray guidance and advanced tools to support image-guided lung procedures. The system is designed specifically for bronchoscopy procedures, enabling clinicians to perform both minimally invasive endobronchial biopsies and lesion ablation during the same procedure. By speeding diagnosis and treatment, Azurion Lung Edition is helping to transform lung cancer care, contributing to dramatically improved outcomes and reduced costs.

Intuitive, integrated, and efficient, the Azurion platform optimizes clinical and operational lab performance and expands the role of image-guided interventions in the treatment of patients. The platform has achieved rapid global adoption and has been used in well over two million procedures worldwide.

Why It Matters

Each year 1.7 million people die worldwide of lung cancer, making it the leading cause of cancer deaths globally and accounting for more loss of life than breast, colon and prostate cancer combined. Today, over 60% of patients are diagnosed at a late stage, with a small chance of a surgical cure. But thanks to a rise in the number of lung cancer screening programs and increasing patient awareness, a growing proportion of patients have small peripheral lesions that are operable.

In addition to early diagnosis, fast treatment is critical to ensure better outcomes and quality of life for lung cancer patients, with every week of delay resulting in a 5% increase in mortality. Today, most patients face a long journey to a definitive diagnosis and they often undergo a painful recovery after open surgery. Cone Beam CT is seen as the gold standard for clinicians to both diagnose and treat lung cancer in one room, and even during the same procedure. 

“Image-guided minimally invasive procedures continue to expand into new treatment areas, enabled by sophisticated, procedure-oriented solutions like Azurion Lung Edition,” said Dr. Gupta. “With lung cancer increasingly being detected at an earlier stage, new minimally invasive treatment strategies like ablation have the potential to significantly improve outcomes for patients.”

Availability

Philips Azurion Lung Edition is available now in the U.S.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: cancer, lung, Lung Cancer, Philips

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |